BAMF
IMGN

BI Asset Management Fondsmaeglerselskab’s Immunogen Inc IMGN Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35,409
Closed -$1.05M – 805
2023
Q4 		$1.05M Sell
35,409
-43,264
-55% -$862K 0.02% 389
2023
Q3 		$1.25M Buy
78,673
+74,377
+1,731% +$1.24M 0.03% 325
2023
Q2 		$81K Buy
+4,296
New +$50.7K ﹤0.01% 674

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's IMGN Position: Q1 2024 in Review

BI Asset Management Fondsmaeglerselskab sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 35,409 shares — an estimated $1.05M sold.

BI Asset Management Fondsmaeglerselskab first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $1.25M in Q3 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 35,409 Immunogen Inc shares in Q1 2024, an estimated $1.05M.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • BI Asset Management Fondsmaeglerselskab's Immunogen Inc position peaked at $1.25M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q1 2024, filed 3 May 2024.